Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.2T | 4.2T | 3.9T | 3.7T |
Cost of revenue | 1.8T | 1.9T | 1.8T | 1.8T |
Gross profit | 2.4T | 2.3T | 2.1T | 1.8T |
Operating expense | ||||
Research & development | 477.4B | 440.7B | 463.7B | 498.4B |
Selling general and admin | 1.7T | 1.7T | 1.6T | 1.7T |
Other operating expenses | 225.1B | 226.7B | 246.4B | 253.7B |
Operating income | -193.4B | -189.6B | -323.8B | -785.5B |
Non operating interest income | ||||
Income | 120.9B | 59.7B | 166.0B | 160.3B |
Expense | 117.7B | 121.4B | 124.7B | 110.4B |
Other income expense | — | — | — | — |
Pretax income | -272.2B | -674.2B | -1.7T | -1.9T |
Tax provision | 94.4B | 251.4B | -10.6B | -29.2B |
Net income | -366.6B | -925.6B | -1.7T | -1.9T |
Basic EPS | — | — | — | — |
Diluted EPS | — | — | — | — |
Basic average shares | — | — | — | — |
Diluted average shares | — | — | — | — |
EBITDA | 196.1B | 362.9B | -1.4T | -1.4T |
Net income from continuing op. | — | — | — | — |
Minority interests | 83.3B | 83.8B | 79.7B | 71.2B |
Preferred stock dividends | 0 | 0 | 0 | 0 |